Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate cancer and a prostatic specific antigen level of 4 ng./ml. or less

Journal of Urology

Volumn 167, Issue 5, 2002, Pages 2025-2031

  D'Amico, Anthony V ^a,b   Chen, Ming Hui ^a,b   Malkowicz, S Bruce ^a,b   Whittington, Richard ^a,b   Renshaw, Andrew A ^a,b   Tomaszewski, John E ^a,b   Samofalov, Yelina ^a,b   Wein, Alan ^a,b   Richie, Jerome P ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Prostate specific antigen; Prostatic neoplasms; Testosterone; Treatment outcome

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0036229514     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65076-8     Document Type: Article

References (15)

1. Preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
2. A pretreatment nomogram for prostate specific antigen recurrence following radical prostatectomy or external beam radiation therapy for clinically localized prostate cancer
3. Large, organ confined, impalpable transition zone cancer: Association with metastatic levels of prostate specific antigen
4. Is low serum free testosterone a marker for high grade prostate cancer?
5. High-grade prostate cancer is associated with lower serum testosterone levels
6. Histologic grading and staging of prostatic carcinoma
7. Using prostate-specific antigen to eliminate the staging radionuclide bone scan
8. Non-parametric estimation from incomplete observations
9. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys
10. Endocrine patterns in patients with benign and malignant prostatic diseases
11. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
12. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors
13. Outcomes for men with clinically nonmetastatic prostate carcinoma manged with radical prostatectomy, external beam radiation therapy, or expectant management: A retrospective analysis
14. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database